JPS60218322A - Product for preventing harm of alcoholic drink, and prepared by utilizing acetic acid-producing bacteria - Google Patents
Product for preventing harm of alcoholic drink, and prepared by utilizing acetic acid-producing bacteriaInfo
- Publication number
- JPS60218322A JPS60218322A JP59076368A JP7636884A JPS60218322A JP S60218322 A JPS60218322 A JP S60218322A JP 59076368 A JP59076368 A JP 59076368A JP 7636884 A JP7636884 A JP 7636884A JP S60218322 A JPS60218322 A JP S60218322A
- Authority
- JP
- Japan
- Prior art keywords
- alcohol
- product
- alcoholic drink
- acetic acid
- harm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Description
【発明の詳細な説明】
近年酒或はアルコール性飲料の消費量は毎年増加を続け
、飲酒による疾病(胃潰瘍、十二指腸潰瘍、肝疾患、急
性、慢性アルコール中毒など)及び運転事故なども急増
している。一般に飲酒する場合、多くのヒトは泥酔では
なく微酔を欲するのが普通であり、そのコントロールが
むずかしいのである。この故に、しばしば二日酔に悩ま
されることにもなる。 1
またヒトによってはアルコール分解酵素が遺伝的に不足
していて、飲酒による赤面、心悸昂進に悩まされ、社交
工種々の障害をうけることになる。[Detailed Description of the Invention] In recent years, the consumption of alcoholic beverages and alcoholic beverages has continued to increase every year, and the number of diseases caused by drinking (gastric ulcer, duodenal ulcer, liver disease, acute and chronic alcohol poisoning, etc.) and driving accidents has also increased rapidly. There is. When drinking alcohol, it is normal for many people to want to be slightly intoxicated rather than completely drunk, and it is difficult to control this. Because of this, they often suffer from hangovers. 1. Also, some humans are genetically deficient in alcohol-degrading enzymes, which causes them to suffer from blushing and heart palpitations due to drinking, and suffer from various social problems.
ここで、酒害とよぶのは、以上に記載した飲酒による障
害の総称である。Here, alcohol damage is a general term for the disorders caused by drinking described above.
この酒害を防止するにはアルコールを消化管(胃、小I
I)で分解し、アルコールの吸収量を飲酒量に比して減
少させることが最も賢明な手段と思われる。しかも、こ
れには、生体に無害で、世異的に古代より現代に至るま
で、醸酢産業に使用され続け、その研究もほぼ完璧に近
く、従って、われわれの知見も深い周知酢酸産生菌を用
いるのが、賢明と思われた。To prevent alcohol damage, alcohol should be kept in the digestive tract (stomach, small I).
I) decomposition and reducing the amount of alcohol absorbed relative to the amount of alcohol consumed seems to be the most prudent means. Furthermore, this is a well-known acetic acid-producing bacterium that is harmless to living organisms, has been used in the vinegar industry from ancient times to modern times, and its research is nearly perfect, so our knowledge is deep. It seemed wise to use it.
酢酸産生菌をこの目的に使用するには、高濃度のアルコ
ールに適用した菌を製造し、これを使用することと、で
きれば、至適pHが酸性、アルカリ性の二種のアルコー
ル分解酵素類を含有づ゛る菌を使用した方がよい。In order to use acetic acid-producing bacteria for this purpose, it is necessary to produce and use bacteria that have been applied to high-concentration alcohol, and if possible, contain two types of alcohol-degrading enzymes whose optimum pH is acidic and alkaline. It is better to use the bacteria that grow.
以上の條件を青痣しながら、100に近い細菌をスクリ
ーニングして、ω(究を完成したのである。Despite the above conditions, we screened nearly 100 bacteria and completed the study.
例1(集菌法)
酢酸産生菌を液体培地で振盪培養したものを、5000
ppmで遠心分離沈澱して、集菌する。なお必要の場
合、集めた菌を水洗後、凍結乾燥する。Example 1 (bacteria collection method) Acetate-producing bacteria were cultured with shaking in a liquid medium, and 5000
PPM centrifugation and sedimentation to collect bacteria. If necessary, the collected bacteria are washed with water and freeze-dried.
液体培地の組成は例えば下記の如くであった。The composition of the liquid medium was, for example, as follows.
例2(生菌と凍結乾燥菌床との酵素活性の比較)例とし
て、Gluconobactor 0xydansにぞ
(するNCIB 9013と^cetobactor
l1que4aciensにぞくするLJ4(Asai
)を撰び、凍結乾燥と云う操作がアルコール分解酵素の
活性に対して大きな影響を与えないことを証明した。実
験成績は表1に総括した。Example 2 (Comparison of enzyme activity between live bacteria and freeze-dried bacterial beds) As an example, Gluconobacter Oxydans (NCIB 9013 and Cetobacter)
LJ4 (Asai) that appeals to l1que4aciens
) and proved that the operation called freeze-drying does not have a large effect on the activity of alcohol degrading enzyme. The experimental results are summarized in Table 1.
菌量は生菌25mg、その生菌mに相当する凍結乾燥菌
床を用いた。pHはHC,Jlで酸性に、またりん酸b
ufferでアルカリ性に調整した。湿度37℃で1時
間攪拌下1ncubateした。アルコール濃度は25
mg/10mで開始。アルコール濃度はDubowsk
i & Withrow(1952)”の方法で測定し
た。The amount of bacteria was 25 mg of live bacteria, and a freeze-dried bacterial bed corresponding to m of live bacteria was used. The pH is made acidic with HC, Jl, and phosphoric acid b
It was adjusted to alkalinity with buffer. The mixture was incubated for 1 hour with stirring at a humidity of 37°C. Alcohol concentration is 25
Start with mg/10m. Alcohol concentration is Dubowsk
I & Withrow (1952).
表 1
例3(凍結乾燥菌のアルコール分解酵素活性の1゜較)
G、oxyaans、八、aceti、A、paste
urianus、A。Table 1 Example 3 (1° comparison of alcoholase activity of freeze-dried bacteria) G, oxyaans, Hachi, aceti, A, paste
urianus, A.
I 1quefaciens、^、perOXydan
S、A、Xy1inUS、F。I 1quefaciens, ^, perOXydan
S, A, Xy1inUS, F.
aurantiaにぞくする菌の凍結乾燥菌のアルコ−
11分解酵素活性の比較を行った。尚、1noculu
n+5izeのほぼ等しい11の培養液から集菌したう
菌を凍結乾燥した菌全吊の酵素活性の比較をも1つだ。Freeze-dried alcohol of bacteria found in aurantia
11-degrading enzyme activities were compared. In addition, 1 noculu
One example is a comparison of the enzyme activity of whole bacterial suspensions obtained by freeze-drying bacteria collected from 11 approximately equal culture solutions of n+5ize.
成績の一部は表2に総括した。Some of the results are summarized in Table 2.
実験はpH2,8、温度37℃、アルコール量251R
g/10me、菌ffl 25 m9.1時間tncu
bat ionの條件で行い、11培養液より得た凍結
乾燥全61ニI W I、 tc。コ(D 成績カラ、
NCIB 9013、u4、IFO13753、IFo
3288などが候補にのぼってきた。The experiment was conducted at pH 2.8, temperature 37℃, and alcohol amount 251R.
g/10me, bacteria ffl 25 m9.1 hour tncu
A total of 61 samples were lyophilized and obtained from 11 culture solutions under the same conditions. Ko (D grade empty,
NCIB 9013, u4, IFO13753, IFo
3288 and others have come up as candidates.
、−V4
″ Ace
CII
^cei
IFo
)Accl
IFo
、Acet
、、、IFO
rat
FO
例4
上述の酢酸産生菌中活性の高いNCIB 9013、u
4(Asai)、IFO13753、IFO3288を
撰び、8濃度のエタノールを含有する培地にadapt
させ、活性を更に上昇させるような操作を行い、下記の
如き活性の高い菌株を得た(表3)。, -V4'' Ace CII ^cei IFo ) Accl IFo , Acet , , IFO rat FO Example 4 NCIB 9013, u with high activity in the acetate-producing bacteria mentioned above
4 (Asai), IFO13753, and IFO3288, and adapted them to a medium containing 8 concentrations of ethanol.
By performing operations to further increase the activity, the following highly active bacterial strains were obtained (Table 3).
本例の成績が示すごとく、例3よりも更に活性の高い菌
の存在を見出した。As shown by the results of this example, the presence of bacteria with even higher activity than in Example 3 was found.
例5(ヒトに対する酢酸産生菌凍結乾燥粉末の効果)
男女各3名計6名を用い、凍結乾燥粉末を投与しないで
エタノールを摂取された場合と凍結乾燥粉末を10分前
に投与してエタノールを摂取した場合のアルコール血中
濃1(BAC)、Heart rateの増減、fin
ger−finger testの変化を比較した。エ
タノールの吸収、タレアランスは固体差が極めて大きい
ことが知られている(2)ので、平均値ではなく、各固
体毎に菌投与の影響を検討した。Example 5 (Effects of freeze-dried powder of acetate-producing bacteria on humans) A total of 6 people (3 men and 3 men) were used. One case was that ethanol was ingested without administering freeze-dried powder, and the other was that ethanol was administered 10 minutes before administration of freeze-dried powder. Blood alcohol concentration (BAC), increase/decrease in Heart rate, fin
Changes in the germ-finger test were compared. Since it is known that there are extremely large individual differences in the absorption and tally balance of ethanol (2), the influence of bacterial administration was examined for each individual rather than the average value.
エタノールは1.0mfl/Kyをオレンジジュースで
30%の濃度(V/V)にうすめて摂取させIC0実験
成績は表4に総括した。各画の効果は明瞭、著明であっ
た。Ethanol was ingested by diluting 1.0 mfl/Ky with orange juice to a concentration of 30% (V/V), and the IC0 experimental results are summarized in Table 4. The effect of each stroke was clear and remarkable.
尚、本実験は朝食をぬいて、空腹時に行ったものである
。This experiment was conducted on an empty stomach after skipping breakfast.
表4
例6(エタノールの吸収を阻害する因子の存在下におけ
る酢酸産生菌凍結乾燥粉末の効果)食物、特に脂肪の豊
富な食物、タンニン、柿などを食べるとエタノールの吸
収がさまたげられることが知られている。実際上述の吸
収抑制因子が共存する時には酢酸産生菌の酒害抑制効果
は更に著明となった。Table 4 Example 6 (Effect of freeze-dried powder of acetic acid-producing bacteria in the presence of factors that inhibit ethanol absorption) It is known that eating food, especially fat-rich foods, tannins, persimmons, etc., inhibits ethanol absorption. It is being In fact, when the above-mentioned absorption-inhibiting factors coexisted, the effect of acetic acid-producing bacteria on suppressing alcohol damage became even more pronounced.
今1例としてタンニン2.00、胃液のpHを2〜3に
増加するように重曹を同時に投与した場合のNCIB
9013と114(Asai)の効果を下記に示す。As an example, NCIB when tannin 2.00 and baking soda were simultaneously administered to increase the pH of gastric juice to 2-3.
The effects of 9013 and 114 (Asai) are shown below.
Claims (6)
テウリア、からなる群から選ばれる、アルコールの酢酸
変換m菌を含有することを特徴とする酒害防止製品。(1) A product for preventing alcohol damage, characterized by containing a bacterium that converts alcohol to acetic acid and is selected from the group consisting of Gluconobacter, Acetobacter, and Frateuria.
特許請求の範囲第1項に記載の製品。(2) The product according to claim 1, which freeze-dries live bacteria and uses it as a granular enzyme.
の製品。(3) The product according to claim 1, wherein the product is a food.
の製品。(4) The product according to claim 1, wherein the product is a drug.
テウリアからなる群から選ばれるアルコールの酢酸変換
細菌とアルコール吸収阻害物質とを含有することを特徴
とする酒害防止製品。(5) An alcoholic beverage prevention product characterized by containing alcohol acetate-converting bacteria selected from the group consisting of Gluconobacter, Acetobacter, and Frateuria and an alcohol absorption inhibitor.
請求の範囲第5項に記載の酒害防止製品。(6) The product for preventing alcohol damage according to claim 5, wherein the alcohol absorption inhibiting substance is tannin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59076368A JPS60218322A (en) | 1984-04-16 | 1984-04-16 | Product for preventing harm of alcoholic drink, and prepared by utilizing acetic acid-producing bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59076368A JPS60218322A (en) | 1984-04-16 | 1984-04-16 | Product for preventing harm of alcoholic drink, and prepared by utilizing acetic acid-producing bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60218322A true JPS60218322A (en) | 1985-11-01 |
JPS645577B2 JPS645577B2 (en) | 1989-01-31 |
Family
ID=13603399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59076368A Granted JPS60218322A (en) | 1984-04-16 | 1984-04-16 | Product for preventing harm of alcoholic drink, and prepared by utilizing acetic acid-producing bacteria |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60218322A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10413769B2 (en) | 2002-09-09 | 2019-09-17 | Reactive Surfaces, Ltd., Llp | Paint having cell wall particulate material with a protective organophosphorus esterase |
-
1984
- 1984-04-16 JP JP59076368A patent/JPS60218322A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10413769B2 (en) | 2002-09-09 | 2019-09-17 | Reactive Surfaces, Ltd., Llp | Paint having cell wall particulate material with a protective organophosphorus esterase |
Also Published As
Publication number | Publication date |
---|---|
JPS645577B2 (en) | 1989-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU709155B2 (en) | Compositions and methods for human gastrointestinal health | |
US6562336B2 (en) | Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria | |
CN109718255A (en) | The preparation method of enzyme powder is still drank after a night in a kind of elimination and the elimination containing the ingredient is still drank after a night and uses composition | |
EP1916911A2 (en) | Use of a symbiotic for the treatment of atopic dermatitis | |
KR102078324B1 (en) | Composition for removing hangover and disorders of intestinal comprising grain-origin lactic acid bacteria | |
CN103820368A (en) | Preparation method and applications of freeze-dried powder of acetic acid bacteria | |
TW200804591A (en) | Lactic acid bacterium having immunoregulatory activity derived from moromi for wine fermentation | |
AU2019201637A1 (en) | Compositions Comprising a Mixture of Bacteria Comprising Pediococcus and Lactobacillus and Methods for Decreasing the Effects of Alcohols | |
CN104605018A (en) | Functional fermented milk and preparation method thereof | |
JP2006199624A (en) | Acetobacter-containing in vivo antioxidative composition | |
JP2016521287A6 (en) | Composition comprising a mixture of bacteria comprising Pediococcus and Lactobacillus, and method for reducing the effects of alcohol | |
US9168274B1 (en) | Method to reduce intoxication from ethanol in humans | |
JP5111752B2 (en) | Antiallergic agent containing Lactobacillus plantarum culture as an active ingredient | |
JP5422200B2 (en) | Liver dysfunction improving agent | |
JP5526320B2 (en) | Intestinal protective agent | |
JPS60218322A (en) | Product for preventing harm of alcoholic drink, and prepared by utilizing acetic acid-producing bacteria | |
JP3029986B2 (en) | Alcohol decomposable composition | |
JP2014005225A (en) | Agent for suppressing appetite improvement and body weight gain | |
JP2876541B2 (en) | Bifidobacterium growth promoter | |
JP5422201B2 (en) | Fermented wort and its use | |
JP4535554B2 (en) | Secondary bile acid production inhibitor and food and drink | |
JP3999894B2 (en) | Intestinal butyric acid bacteria growth promoter | |
CN111107854A (en) | Composition for relieving hangover or composition for preventing, improving or treating alcoholic liver disease containing β -glucan as active ingredient | |
JP3261571B2 (en) | Method for improving survival of bifidobacteria | |
JP2756778B2 (en) | Foods and drinks containing cholesterol lowering agents |